Piper Jaffray Broadens Medical Technology Research Expertise with Addition of Matt Miksic
May 22 2008 - 10:15AM
Business Wire
Piper Jaffray has hired Matt Miksic to broaden the investment
research team�s coverage of the medical technology sector. As a
senior research analyst, Miksic will provide coverage of
ophthalmology, orthopedics and diversified medical technology
companies. He will be based in the firm�s New York office. Miksic
joins Piper Jaffray from Morgan Stanley where he was a senior
research analyst covering the medical technology and hospital
supply sectors. Prior to Morgan Stanley, he gained experience as a
senior manager in the business consulting division at Arthur
Andersen and also spent five years with a software start-up
company. Miksic earned a bachelor�s degree in computer science from
Rutgers University and a Master of Business Administration degree
from the Leonard N. Stern School of Business at New York
University. �Matt�s addition to the investment research team will
allow us to continue providing quality investment recommendations
and independent research in the medical technology sector,� said
Steve Buell, head of investment research at Piper Jaffray. �With
his proven track record, we are well-positioned for broadening our
expertise and building on our leading health care research
franchise.� Miksic has provided primary coverage for several
high-profile medical technology companies, including Beckman
Coulter, Biomet, Dade Behring, Hospira, Integra LifeSciences,
Kyphon, LifeCell, NuVasive, Respironics, Stryker and Zimmer. About
Piper Jaffray Piper Jaffray Companies is a leading, international
middle-market investment bank and institutional securities firm,
serving the needs of middle-market corporations, private equity
groups, public entities, nonprofit clients and institutional
investors. Founded in 1895, Piper Jaffray provides a comprehensive
set of products and services, including equity and debt capital
markets products; public finance services; mergers and acquisitions
advisory services; high-yield and structured products;
institutional equity and fixed-income sales and trading; and equity
and high-yield research. With headquarters in Minneapolis, Piper
Jaffray has 25 offices across the United States and international
locations in London, Hong Kong, and Shanghai. Piper Jaffray &
Co. is the firm's principal operating subsidiary. (NYSE: PJC)
(http://www.piperjaffray.com) Since 1895. Member SIPC and FINRA. �
2008 Piper Jaffray & Co., 800 Nicollet Mall, Suite 800,
Minneapolis, Minnesota 55402-7020
Piper Jaffray Companies (NYSE:PJC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Piper Jaffray Companies (NYSE:PJC)
Historical Stock Chart
From Jul 2023 to Jul 2024